Absci (ABSI) Cash from Investing Activities (2020 - 2026)

Absci's (ABSI) quarterly Cash from Investing Activities came in at $7.4 million in Q1 2026, up 148.94% year-on-year from $3.0 million in Q1 2025, and down 62.34% quarter-over-quarter from $19.5 million in Q4 2025.

Absci (ABSI) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Absci has disclosed Cash from Investing Activities across 7 years of filings, most recently posting $7.4 million for Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at $7.4 million, up 148.94% year-over-year; the trailing twelve-month figure through Mar 2026 was -$27.8 million (down 238.35% YoY), and the FY2025 annual result was -$50.2 million, down 20.64% from the prior year.
  • Cash from Investing Activities came in at $7.4 million for Q1 2026 at Absci, down from $19.5 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $70.2 million in Q2 2023 to a low of -$78.7 million in Q3 2022.
  • The 5-year median for Cash from Investing Activities is $1.3 million (2024), against an average of -$7.6 million.
  • Across the five-year window, Cash from Investing Activities slumped 1054.3% in 2022 and surged 725.07% in 2023, its largest moves.
  • Absci's Cash from Investing Activities stood at -$30.2 million in 2022, then soared by 162.82% to $19.0 million in 2023, then advanced by 0.45% to $19.0 million in 2024, then climbed by 2.65% to $19.5 million in 2025, then tumbled by 62.34% to $7.4 million in 2026.
  • The last three Cash from Investing Activities figures came in at $7.4 million (Q1 2026), $19.5 million (Q4 2025), and -$63.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Absci 1.13 Bn 1.01 Bn - 7.36 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.36 Mn
Mar 31, 2026 7.36 Mn
Dec 31, 2025 19.55 Mn
Dec 31, 2025 19.55 Mn
Sep 30, 2025 -63.70 Mn
Sep 30, 2025 -63.70 Mn
Jun 30, 2025 9.04 Mn
Jun 30, 2025 9.04 Mn
Mar 31, 2025 -15.04 Mn
Mar 31, 2025 -15.04 Mn
Dec 31, 2024 19.04 Mn
Dec 31, 2024 19.04 Mn
Sep 30, 2024 14.81 Mn
Sep 30, 2024 14.81 Mn
Jun 30, 2024 1.26 Mn
Jun 30, 2024 1.26 Mn
Mar 31, 2024 -76.68 Mn
Mar 31, 2024 -76.68 Mn
Dec 31, 2023 18.96 Mn
Dec 31, 2023 18.96 Mn